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ABSTRACT
Introduction: In this study the authors review the outcomes of 22 patients with medically refractory epilepsy
and slow growth brain tumors. Objectives: Evaluate the clinical, electrophysiological, operative, and
histopathological features. Patients and Results: The majority of the tumors were located in the temporal
lobe (n = 20) and involved the cortical gray matter. The most frequent tumors were gangliogliomas (n = 9),
astrocytomas grade I and II (n = 6), dysembryoplastic neuroepithelial tumors (n = 5) and ganglioneuroma
(n = 2). The biological behavior of the tumors was strikingly indolent, as indicated by a long preoperative
history of chronic seizures (mean, 14 years). Mean follow-up time after resection was 27 months, and according
to Engel’s classification, 85% were seizure-free, 10% showed a reduction of seizure frequency of at least 90%,
and 5% had reduction in seizure frequency at least 75%. Conclusion: The data indicate that neoplasms
associated with pharmacoresistent epilepsy constitute a distinct clinicopathological group of tumors that
arise in young patients, involve the cortex, and exhibit indolent biological behavior for many years. Complete
surgical removal of these tumors, including the epileptogenic area, can achieve excellent seizure control.
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RESUMO
Avaliação clínica e tratamento cirúrgico de pacientes com tumores cerebrais indolentes e epilepsia
Introdução: Neste estudo os autores avaliaram retrospectivamente 22 pacientes tratados cirurgicamente
com diagnóstico de epilepsia refratária e tumor cerebral de crescimento lento. Objetivos: Avaliar os aspec-
tos clínicos, eletrofisiológicos, cirúrgicos e histopatológicos. Pacientes e Resultados: A maioria dos tumores
estava localizada no lobo temporal (n = 20) com envolvimento da substância cinzenta. Ganglioglioma foi o
tumor mais frequente (n = 9), seguido do astrocitoma grau I e II OMS (n = 6), tumor neuroepitelial
disembrioplástico (DNET) (n = 5) e ganglioneuroma (n = 2). O comportamento biológico dos tumores foi
estritamente indolente como indicado pela longa história pré-operatória de (média, 14 anos). O tempo de
acompanhamento pós-operatório médio foi de 27 meses e de acordo com a Classificacão de Engel, 85%
ficaram sem crises (Classe I), 10% obtiveram redução maior de 90% das crises (Classe II), e 5% tiveram
redução menor que 75% (Classe III). Conclusão: Os dados indicam que neoplasias associadas à epilepsia
crônica refratária constituem um grupo de tumores com características clinico-patológicas distintas que se
iniciam em pacientes jovens, envolvem o córtex e apresentam comportamento biológico indolente. A
ressecção cirúrgica completa destes tumores, incluindo a zona epileptogênica, levou ao controle total das
crises na maior parte dos casos estudados.
Unitermos: tumores cerebrais indolentes, epilepsia, tratamento cirúrgico.
Received Mar 30, 2007; accepted May 15, 2007.
66
INTRODUCTION
Seizures constitute the presenting manifestation of
intrinsic brain tumors in 37 to 92% of patients.7 The
incidence of seizures is related to the location and the
growth and pathological characteristics of tumors.2 Slowly
growing and cortically located low-grade tumors, such as
gangliogliomas and oligodendrogliomas, represent the
tumors with the greatest epileptogenic potential. With the
use of neuroimaging techniques, these lesions are more
readily diagnosed.1,2
The optimal treatment of epilepsy-associated tumors
is a controversial issue because the very benign nature of
many of these lesions seems to differ from the more
common glial tumors in other settings.3 Therapeutic goals
include not only the removal of the lesion with its risks
for malignant dedifferentiation or hemorrhage but also the
control of seizures. The relationships between lesions
and epileptogenicity, however, are complex. Therefore,
different surgical approaches have been used successfully,
such as lesionectomy,4 nontailored en bloc resection,3,5 and
tailored surgery.6
During the past decade, high-resolution magnetic
resonance imaging (MRI) as well as improved pre- and
intraoperative electrophysiological mapping procedures
have greatly increased our knowledge about the epilepto-
genic lesion and the extent of the resective surgery. The
aim of the present study was to analyze the clinical,
radiological, and histopathological features in a recent
series of 22 patients with tumor-associated chronic epilepsy
and to evaluate their seizure outcomes in relation to
various parameters.
PATIENTS AND METHODS
Between May 2002 and November 2006, a total of 22
patients underwent resective surgery (temporal, n = 20;
extratemporal, n = 2) for medically intractable epilepsy.
All patients had well-documented chronic and medically
intractable epilepsy lasting for a minimum of 4 years. For
all patients, incomplete seizure control at maximal
tolerable serum levels of at least two first-line anti-
convulsant agents, such as carbamazepine, phenytoin,
phenobarbitone, or valproic acid, had to be proven before
they were referred for presurgical evaluation. Complex
partial seizures were observed in 18 patients, and simple
partial seizures were observed in 4 patients. A history of
secondarily generalized tonic-clonic seizures was present
for 11 patients.
All patients underwent continuous, noninvasive video
electroencephalographic monitoring with scalp and sphenoi-
dal electrodes. Noninvasive evaluation was considered
sufficient if the site of seizure origin was congruent with
the location of the tumor. Electrocorticographic (ECoG)
studies were performed in 6 of the 22 patients (27%).
The decision about the site and the extent of the
resection was based mainly on the delineation of the zones
of seizure origin and persistent interictal epileptiform
activity as well as the location of the neoplasm, as
determined by MRI. Hippocampal tissue was resected only
if there was clear evidence from ictal recordings and
sclerosis signs on MRI. The diagnosis of Ammon’s horn
sclerosis was based on the following criteria: increased
signal on T2-weighted images and temporomesial atrophy.
The extent of the hippocampal resection depended on the
memory performance of neuropsycologic tests, and ranged
between 1.5 and 2.8 cm.
All preoperative MRI studies were retrospectively
evaluated by the same neuroradiologist. The imaging
procedure usually included sagittal T1-weighted images
(TR, 500-600 ms; TE, 15-25 ms; slice thickness, 8-10 mm),
axial proton-density and T2-weighted images (TR, 2000-
2500 ms; TE, 20-30 and 80-120 ms; slice thickness,
6-8 mm), and spin echo scans. T2-weighted gradient echo
scans were performed only rarely. In addition, coronal and
axial T1-weighted images with and without gadolinium
diethylene triamine penta-acetic acid were acquired with
similar parameters. For patients with an assumed temporal
lobe epilepsy, axial images were acquired with a modified
angulation at about 25 degrees off the orbitomeatal line
and parallel to the long axis of the hippocampus.
All operations were performed under general anes-
thesia. In the temporal lobe (n = 20), the following
surgical procedures were performed: anterior temporal
lobectomy with hippocampectomy (n = 11), lesionectomy
without hippocampectomy (n = 5) and temporodorsal
lesionectomy (n = 4). These different forms of temporal
resections were primarily determined by the location of
the tumor and the distribution of the epileptiform activity.
Extratemporal resections (n = 2) included frontal (n = 1)
and parietal (n = 1) lesionectomy, according to the results
of the electrophysiological evaluation. Intra-operative
electrocorticography for the delineation of the limits of
the resection was performed in 6 cases. In all cases a
complete removal of the lesion was intended. The
function of intraoperative monitoring was to provide
data regarding whether an additional resection of tissue
beyond this margin was necessary and where it was located.
All slides of operative specimens were reviewed by the
same neuropathologist. Hematoxylin-and-eosin-stained
sections were available from all the cases. For the majority
of specimens, there were also Nissl stains and one or all
of the following immunohistochemical reactions were
performed: glial fibrillary acid protein, synaptophysin
and neurofilament protein. The tumors were classified
according to the revised WHO classification for tumors of
the nervous system.
Follow-up information, available from all 22 patients,
was based on regular visits at 3- to 6 month intervals.
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The postoperative observation times ranged from 6 to
35 months (mean, 27 months). With respect to the
postoperative seizure state, patients were assigned to four
different outcome classes, as described by Engel et al.:12
I, seizure-free or only auras since surgery; II, rare seizures
(> 90%); III, reduction of seizure frequency³ 75%; and
IV, unchanged (< 75% reduction of seizure frequency).
Figure 1. Ganglioglioma.
Figure 2. Dysembrioplastic Neuroepithelial Tumor (DNET).
Figure 3. Astrocytoma Grade II.
Student’s t test was used for a statistical comparison
of continuous variables, if the distribution was normal, and
Wilcoxon’s test was used if it was not. Discrete variables
were compared by cross tabulation tests.
RESULTS
There were 9 male and 12 female patients, ranging in
age from 18.2 to 42.3 years (mean, 26.7 years). The mean
age at the onset of seizures was 12.7 years. The duration
of epilepsy varied between 3 and 21 years, with a mean of
14.0 years. Seizure onset and duration related to the
histopathological diagnoses showed no statistical signifi-
cance.
The majority of tumors (n = 20) were located in
the temporal lobe. Sixteen of them (80%) involved mesial
temporal structures (hippocampus, parahippocampal
gyrus, amygdala, and uncus). The remaining temporal
tumors (20%) were in a neocortical location. Extra-
temporal tumors involved cortical structures (frontal
and parietal). The tumor location was not related
to the histopathological diagnoses (no statistical
significance).
The most frequent tumors were gangliogliomas (n = 9),
astrocytomas grade I and II (n = 5), dysembryoplastic
neuroepithelial tumors (n = 5) and ganglioneuroma (n = 2).
The presence of Ammon’s horn sclerosis in addition to a
neoplasm (dual pathology) occurred in 11 of 22 patients
in whom the hippocampus was resected.
There was no permanent morbidity in our patients or
mortality. According to Engel’s classification, 85% were
seizure-free, 10% showed a reduction of seizure frequency
of at least 90%, and 5% had reduction in seizure frequency
at least 75%.
The most favorable results were observed in patients
with gangliogliomas. With this histopathological diagnosis,
89% of patients were seizure-free. The ratio of seizure-
free patients with others tumors was lower (64%). These
differences were statistically significant (p < 0.05).
DISCUSSION
In a number of series, the majority of neoplastic lesions
found in patients with intractable seizures were gliomas.9-11
In our study, all tumors were of a low histopathological
grade (WHO Grades I or II), whereas in most other
reported series, the ratio of malignant tumors ranges
between 10 and 20%.11,12 In accordance with the expe-
rience of Olivier et al.,13 gangliogliomas were the most
common entity, accounting for 45% of all tumors, followed
by astrocytomas (25%). The dysembryoplastic neuro-
epithelial tumors, described in 1988 by Daumas-Duport
et al.,9 is characterized by an intracortical location,
multinodular architecture, and a heterogeneous cellular
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composition, including astrocytes, oligodendrocyte-like
cells, and neurons. In the present study, most dysembryo-
plastic neuroepithelial tumors were localized temporo-
mesially. Despite principal differences in the cellular
composition and biological behavior of dysembryoplastic
neuroepithelial tumors and oligodendrogliomas, these
tumors may show a great resemblance histopathologically.
Therefore, it is likely that many epilepsy-associated tumors
that previously have been reported as oligodendrogliomas
would be classified as dysembryoplastic neuroepithelial
tumors according to current diagnostic concepts.15 This
may account for the high incidence of oligodendrogliomas
in patients with seizures, as reported in a number of
series.16-19
According to the recent literature, the median survival
of patients with low-grade gliomas ranges between 3 and
8 years.20 Death usually occurs from the malignant
transformation of the original tumor.21,22 Although post-
operative long-term results are not available in this series,
the majority of our tumors seem to have a rather indolent
course, as suggested by the long history of epilepsy. These
data are consistent with the literature.15,17,22
In the present series, 85% of patients became seizure-
free and all patients experienced a worthwhile improve-
ment after surgery. There were no significant differences
in seizure outcome when temporal and extratemporal
resections were compared.
Understanding the spatial and causal relationships
between structural lesions and epilepsy is essential to
rational therapeutic strategies. Favorable results have been
reported after lesionectomy, with a percentage of seizure-
free patients ranging from 65 to 90%.22 These data suggest
that in a subset of patients, the cortex surrounding
the tumor loses the ability to independently initiate
and propagate seizures once the tumor itself has been
removed.11,15
Particularly in the temporal lobe, the results of
lesionectomy alone are disappointing. Only 22% (two of
nine patients) with temporal lesions in the series presented
by Cascino et al.5 became seizure-free. When the tumor
directly involves the hippocampus, the decision to
undertake a mesial resection is relatively clear. However,
when the tumor presents no involvement of mesial
structures, careful consideration must be given to the
potential risks and benefits of a mesial resection. In this
situation, the data acquired from neuropsychological
testing may be useful to support the decision to proceed
with mesial tissue removal.
The development of optimal treatment protocols for
patients with lesions associated with focal epilepsy would
be enhanced by a better understanding of the fundamen-
tal pathophysiological or biochemical processes of seizure
generation.17 Further investigations are likely to improve
our understanding of the pathophysiological basis of
tumor-associated epilepsy and, ultimately, our ability to
identify patients in whom a lesionectomy alone is sufficient
and those in whom additional resection of the epilepto-
genic zone is required to achieve optimal seizure control.12
If the tumor or the epileptogenic zone involves cortical
areas of high functionality, such as the language or motor
cortex, a complete resection of these areas would be
accompanied by a significant neurological deficit. In these
cases, functional considerations have to be weighed against
seizure and tumor control. Because of the individual va-
ria-bility in the organization of cortical function,17,18 intra-
or extra-operative electrical stimulation mapping has proven
to be useful in determining the extent of the resection.
CONCLUSIONS
Low-grade tumors associated with intractable seizures
constitute a distinct clinicopathological group of benign
intrinsic brain tumors. Characteristically, these tumors
involve the gray matter, arise in young patients, and exhibit
stable behavior for many years. Complete resection of these
tumors provides the most important condition for seizure
control. Therapeutic goals include not only the seizure
control, but also de histopathologic diagnosis and minimize
the risks for malignant dedifferentiation or hemorrhage.
Lesionectomy is successful in a limited number of patients,
and additional excision of an epileptogenic zone, as
determined by intraoperative or extraoperative studies, is
needed to achieve satisfactory seizure outcome.
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